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Abstract
Background: Significant inconsistencies between probe-to-gene annotations between different
releases of probe set identifiers by commercial microarray platform solutions have been reported.
Such inconsistencies lead to misleading or ambiguous interpretation of published gene expression
results.
Results: We report here similar inconsistencies in the probe-to-gene annotation of Applied
Biosystems AB1700 data, demonstrating that this is not an isolated concern. Moreover, the online
information source PANTHER does not provide information required to track such
inconsistencies, hence, even correctly annotated datasets, when resubmitted after PANTHER was
updated to a new probe-to-gene annotation release, will generate differing results without any
feedback on the origin of the change.
Conclusion: The importance of unequivocal annotation of microarray experiments can not be
underestimated. Inconsistencies greatly diminish the usefulness of the technology. Novel methods
in the analysis of transcriptome profiles often rely on large disparate datasets stemming from
multiple sources. The predictive and analytic power of such approaches rapidly diminishes if only
least-common subsets can be used for analysis. We present here the information that needs to be
provided together with the raw AB1700 data, and the information required together with the
biologic interpretation of such data to avoid inconsistencies and tracking difficulties.
Results
Studying the cellular transcriptome and its dynamics
using microarray technology has become a common place
application in modern biomedical research [1]. Dedicated
databases [i.e. [2-4]] store several hundreds of individual
microarray datasets and are growing exponentially. Many
different commercial and research originating microarray
formats and platforms are being used [2-4]. Since micro-
array technology currently can not be used to determine
absolute expression levels of genes, comparative analysis
of transcriptome data across different biological condi-
tions is challenging. Cross-platform comparisons can
only be carried out if coherent mapping of genes between
the platforms and their particular probe-to-gene and gene-
to-genome annotations can be achieved. The public
microarray databases are very valuable as here standard
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formatting and annotation procedures are being imposed,
thereby rendering the individual microarray experiments
useful beyond the immediate purpose they were acquired
for [4,5].
Since both the genome sequences as well as individual
gene annotations are subject to constant discovery-driven
change, probe-to-gene annotations undergo frequent revi-
sions. Such revisions of the initial probe-to-gene mapping
lead to inconsistencies if they are not well controlled [6].
Today any dataset requires to be published together with
the probe-to-gene annotation used for biological analysis
or an explicit reference to a static open-source of such.
Unfortunately, this is not state-of-the-art yet, and we join
in the call for more sensitivity towards this issue [6].
We show here that for Applied Biosystems AB1700
Genome Survey Arrays the same contention of potential
inconsistencies in the probe-to-gene annotations holds
true if several precautions are not taken.
Applied Biosystems AB1700 (ProdNo: 4338036) technol-
ogy [7], has only recently been commercialized and
applied to biomedical research [8]. Design particularities
such as the use of 60 mer oligonucleotide probes and the
use of chemiluminescence as means of signal detection
result in greater sensitivity as comparable commercial
platforms. Until present microarray slides for human,
mouse, and rat have been developed [7,9-11]. For the
Human Genome Survey Arrays (HGS) already a second
generation of slides are being commercialized (2.0:
ProdNo: 4359029, first release 1.0: ProdNo: 4337467),
which contain probes for 29098 individual genes of
which >8000 are not covered by other commercial solu-
tions [9] (Figure 1).
The probe-sets as well as the probe-to-gene annotations
(PGAs) for AB1700 technology are revised regularly. In
order to assure correct and unambiguous interpretation of
AB1700 data, we incite particular attention to the follow-
ing aspects:
PGA revisions, unless tracked and conserved by the user 
lead to inconsistencies and ambiguities in the 
interpretation of AB1700 data
Significant changes between probe-to-gene releases and
microarray versions in Applied Biosystems AB1700 data
are also observed. The conclusions drawn from the very
same experimental dataset will differ depending on the
particular PGA version used. In order to retain transpar-
ency, the microarray data need thus to be annotated with
the PGA version used for interpretation. Currently,
AB1700 PGA files are not date-stamped and simply
replaced by revised versions in the AB Gene Expression Sys-
tem Software [12] once those become available. The
AB1700 user has therefore to keep copies of back-versions
and a mapping of datasets to PGA files. This problematic
has been previously discussed for an analogous case [6].
AB1700 PGAs are not publicly available, and the 
PANTHER web-source can not be used for third party 
verifications
Third parties have no direct access to the AB1700 PGA
files. Independent verification of published results could
thus only be achieved using the Applied Biosystems PAN-
THER web-source which is similar in function to NetAffx
[13-16]. The user hereby can upload, temporally store,
and analyze datasets containing gene or probe IDs and
associated signal measurements. PANTHER's use of Hid-
den Markov Models (HHMs) and protein-family trees
clearly provides for significant insights into the nature of
the biologic problem studied, and is frequently used by
research.
PANTHER internally operates on a continuously updated
probe-to-gene annotation table, whereas the PGA releases
are communicated discontinuously. Today there is no way
of tracking and/or recording the continuous updates.
PANTHER also contains only information on protein cod-
ing genes. The completeness of the internal PGA is further
compromised by excluding GenBank-only mRNAs as they
usually do not contain associated protein information. By
consequence, published lists of gene or probe IDs with
associated PANTHER pathways analyses are ambiguous,
Venn diagrams comparing the different unique probe and  gene sets according to probe-to-gene annotation releases  and array versions Figure 1
Venn diagrams comparing the different unique probe 
and gene sets according to probe-to-gene annotation 
releases and array versions. For explanation on gene ID 
suffixes, please refer to paragraph 5. Obsolete gene IDs and 
nomenclature suffixes. A1.0 = Human Genome Survey Array 
1.0; A2.0 = Human Genome Survey Array 2.0; V1 = probe-
to-gene annotation release 1; V2 = probe-to-gene annotation 
release 2.
HGS 1.0 - PGA V2 HGS 2.0 - PGA V2
30469 33096 32878
Probe IDs
30617 33096 32878
Gene IDs (considering suffix)
HGS 1.0 - PGA V2 HGS 2.0 - PGA V2
26861 27858 28891
Gene IDs (ignoring suffix)
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potentially incomplete, and the interpretation is not nec-
essarily verifiable by a third party.
Several probes for a single gene
Probe design for the AB1700 has been guided by the idea
to have a single probe targeting all isoforms of a given
gene. This is, due to alternative splicing, alternative pro-
moter usage, and likely also to annotation errors, not pos-
sible for about 13% of all HGS V2.0 represented genes,
which are consequently quantified using up to ten differ-
ent probes on the array [9-11]. The probe signal intensi-
ties are determined individually and need to be kept
separate during primary analysis of the data [12]; a chal-
lenge for automated data analysis, as the existence of mul-
tiple probes for a single gene is not evident from the gene
ID or probe ID alone. A look-up table needs to be com-
piled in order to establish proper mapping between any
given gene ID and its single or multiple probes for every
new PGA release [see Additional file 1] [see Additional file
2]. Finally, the logic used to integrate the different signals
for a single gene needs to be communicated in order to
achieve transparency for third parties.
Several gene IDs for a single probe
Many spotted probes are also not mono-specific for a sin-
gle gene. In cases of significant cross-reactivity, e.g. with
closely related members of a gene family, not only a pri-
mary gene ID is listed in the PGA tables but in addition,
as a separate entry, a list of alternate gene IDs the probe
cross-hybridizes with. The existence of multiple tran-
scripts hybridizing to a single probe is obviously not sys-
tematic, but also not appreciable from the probe ID
nomenclature. Hence a dedicated look-up table needs to
be generated.
Obsolete gene IDs and nomenclature suffixes
In the PGA table a specific column indicates whether the
relationship between a given probe ID and the primary
Table 2: Probe/Gene IDs for MAPKK3. The different probe and gene IDs corresponding to the two annotation releases (V& and V2) 
where submitted to PANTHER with the listed results. This table summarizes for a single gene the differences and potential 
ambiguities when submitting gene IDs rather than probe IDs, and illustrates the effect of curation status (obsolete vs. valid) or 
annotation release. Note that >70% of all gene IDs in the current HGS V2 PGA table carry suffixes, that ~13% of all represented genes 
have more than one probe ID associated, and that probes often have secondary hits. All of these require different look-up tables to be 
generated by the user in order to achieve coherency and transparency in the data analysis process.
if Probe IDs (V1) are submitted: if the Gene IDs (V1) are submitted:
Probe ID (V1) Gene ID (V1) PANTHER SCORE PANTHER Gene ID PANTHER SCORE PANTHER Gene ID
235514 hCG1993739 2 × 10E-23 hCG1993739 2 × 10–23 hCG1993739
127877 hCG1993739.1 6 × 10E-80 hCG28371
182262 hCG1993739.1 3 × 10E-70 hCG1980405
234450 hCG1993739.1 6 × 10E-58 hCG1997534
if Probe IDs (V2) 
are submitted:
if the Gene IDs 
(V2) are submitted:
Probe ID (V2) Gene ID (V2) PANTHER SCORE PANTHER Gene ID PANTHER SCORE PANTHER Gene ID
235514 hCG1993739 2 × 10E-23 hCG1993739 2 × 10–23 hCG1993739
127877 hCG1993739.2 6 × 10E-80 hCG28371
182262 hCG1993739.2 3 × 10E-70 hCG1980405
234450 hCG1993739.2 6 × 10E-58 hCG1997534
171301 hCG1993739.2 - -
Table 1: PANTHER annotation versus disseminated annotation releases 1 & 2. The data from the Supplementary Files 1 & 2 were 
submitted to the PANTHER website either using the probe IDs or the gene IDs. The differences in identification, display, and absentee 
calls, between the datasets and the annotation releases are due to the fact that PANTHER is continuously updated, only considers 
protein coding genes, excludes GenBank-only annotated mRNAs, and retains only the gene ID with the highest suffix.
Number of unique entries ~
Annotation 
Version
Probe ID/Gene 
ID set
submitted found by 
PANTHER
displayed by 
PANTHER
not found by 
PANTHER
not accounted 
for
V1 Probe ID 51 30 29 21 0
Gene ID 51 44 22 2 5
V 2 P r o b e  I D 1 1 0 6 55 94 5 0
Gene ID 110 98 44 0 12BMC Bioinformatics 2005, 6:307 http://www.biomedcentral.com/1471-2105/6/307
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gene ID is still valid or has become obsolete during anno-
tation revisions. This information should be applied ret-
roactively to previous annotations of a dataset, and
obsolete gene IDs replaced by the current ones if they are
available. A number of probes also do no longer match to
any known gene. For coherence reasons the primary gene
ID listed in the PGA table corresponds to last previously
valid entry, and the status is set to obsolete. Curation sta-
tus of gene annotations is indicated by attaching a version
number (suffix) to the gene ID. The probe-to-gene anno-
tation tables provided by the manufacturer list as primary
gene ID for 28366, or greater 97% of all represented
genes, the Celera Genomics gene nomenclature ID. Com-
parison with other platforms and publicly annotated
genes is hence cumbersome, but since public IDs are also
provided for the 22271 transcripts that can be matched,
possible. A total of 23300 gene IDs (PGA V2), or >70%
the Celera Genomics nomenclature, is suffixed (i.e.
hCG123456.4). A single gene ID can be found within a
single release on a single array associated with multiple
probes, only differing in the annotation/curation status
suffix (a total of 23 gene IDs concerned in annotation
release V1; a total of 44 gene IDs concerned in release V2,
[see Additional file 1] [see Additional file 2]). The highest
running suffix thereby indicates the current state of the art.
Lower suffixes correspond to obsolete annotations, and
no further information or updates are provided for those
gene IDs. The PANTHER database retains for analysis only
the highest suffixed gene ID in the submitted set of gene
IDs, however without indicating the precise numerical
value as they are truncated (Table 1). This practically
excludes the option of using PANTHER with sets of gene
IDs rather than probe IDs. Moreover, yet another PGA ver-
sion-specific look-up table needs to be compiled to assure
that always the gene ID with the highest ranking suffix is
used for the biological interpretation of the data based on
gene IDs. The potential confusion is illustrated with the
example of PANTHER HMM scores for the Mitogen Acti-
vated Protein Kinase Kinase 3 – MAPKK3, which possesses
four (V1) or five (V2) associated probes and two gene ID
curation versions (Table 2). Given above, since PANTHER
is continuously updated, we suggest that submission files
are generated and downloaded whenever PANTHER is
used with AB1700 data, and that these files are carefully
stored together with the biologic or statistic interpretation
of the data.
Conclusion
The importance of unequivocal annotation of microarray
experiments is evident. The analytical power of novel
technologies such as the AB1700 platform from Applied
Biosystems [7] certainly could be curtailed by incorrect
annotation and failure to statically associate the correct
annotations with the data.
In order to maintain a maximum of transparency and con-
sistency, we conclude that such microarray data can only
be analyzed based on probe IDs rather than gene IDs, and
need to be supplemented with the following information
for purposes of publication and reanalysis: (i) the micro-
array version, (ii) the probe-to-gene annotation release
used, (iii) how multiple probes for a single gene, and (iv)
how probe cross-reactivity have been considered. In case
PANTHER was used for analysis: (v) which probe and
gene corresponds to the HMM scores, and finally (vi) a
submission record-file generated by PANTHER at the
same time the statistical and biological analysis was per-
formed.
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As discussed in the text, not only multiple probes can exist for a single 
gene, but also multiple gene IDs. These gene IDs differ by a numerical 
extension or suffix. They represent the curation status of the gene annota-
tion. Numerically lower suffixes do not have any further annotation infor-
mation in the probe-to-gene annotation releases, however, are retained for 
"coherence" reasons. This table lists all obsolete probe ID vs. gene ID 
annotations. Such look-up tables need to be generated by AB1700 users 
for each PGA [see Additional file 2].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-6-307-S1.txt]
Additional File 2
This file collects the same information as [see Additional file 1] just for 
the probe-to-gene annotation release 2.
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